Sonida Senior Living Past Earnings Performance
Past criteria checks 0/6
Sonida Senior Living has been growing earnings at an average annual rate of 30.2%, while the Healthcare industry saw earnings growing at 5.3% annually. Revenues have been declining at an average rate of 16.4% per year.
Key information
30.2%
Earnings growth rate
43.2%
EPS growth rate
| Healthcare Industry Growth | 8.5% |
| Revenue growth rate | -16.4% |
| Return on equity | -8.6% |
| Net Margin | -6.6% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Sonida Senior Living: Soaring Demand, Limited New Supply, And A Low Valuation
Oct 08Sonida Senior Living: Leverage Declining But Remains At High Levels
Jul 19Sonida Senior Living, Inc.'s (NYSE:SNDA) Popularity With Investors Under Threat As Stock Sinks 26%
Jun 11
There's Reason For Concern Over Sonida Senior Living, Inc.'s (NYSE:SNDA) Massive 164% Price Jump
Mar 27Optimistic Investors Push Sonida Senior Living, Inc. (NYSE:SNDA) Shares Up 164% But Growth Is Lacking
Mar 27Sonida Senior Living, Inc.'s (NYSE:SNDA) Shares Lagging The Industry But So Is The Business
Sep 29Sonida Senior Living: Debt Restructuring Yet To Drive Inflows, Reiterate Hold
Aug 10Sonida Senior Living: No Change To Hold Thesis Following Latest Developments
Dec 15Sonida Senior Living GAAP EPS of -$2.34, revenue of $60.78M
Nov 14Sonida Senior Living: Unattractive Operating Metrics Mitigate Buy Rating
Aug 28Sonida Senior Living GAAP EPS of -$1.34, revenue of $59.64M
Aug 12Sonida Senior Living announces leadership transition
Aug 04Capital Senior Living announces 1-for-15 reverse stock split
Dec 09Capital Senior Living starts transfer of 18 communities to Fannie Mae
Dec 08Capital Senior Living Corporation 2020 Q3 - Results - Earnings Call Presentation
Nov 08Capital Senior Living EPS of -$2.15
Nov 05Revenue & Expenses Breakdown
How Sonida Senior Living makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 253 | -17 | 38 | 0 |
| 30 Jun 24 | 245 | -21 | 35 | 0 |
| 31 Mar 24 | 238 | -23 | 32 | 0 |
| 31 Dec 23 | 234 | -26 | 32 | 0 |
| 30 Sep 23 | 228 | -28 | 29 | 0 |
| 30 Jun 23 | 222 | -23 | 26 | 0 |
| 31 Mar 23 | 217 | -20 | 29 | 0 |
| 31 Dec 22 | 211 | -59 | 30 | 0 |
| 30 Sep 22 | 207 | -61 | 32 | 0 |
| 30 Jun 22 | 204 | -9 | 33 | 0 |
| 31 Mar 22 | 199 | 48 | 33 | 0 |
| 31 Dec 21 | 194 | 105 | 32 | 0 |
| 30 Sep 21 | 211 | 104 | 38 | 0 |
| 30 Jun 21 | 247 | -148 | 47 | 0 |
| 31 Mar 21 | 300 | -209 | 53 | 0 |
| 31 Dec 20 | 359 | -295 | 65 | 0 |
| 30 Sep 20 | 400 | -265 | 73 | 0 |
| 30 Jun 20 | 425 | -70 | 81 | 0 |
| 31 Mar 20 | 439 | -70 | 90 | 0 |
| 31 Dec 19 | 447 | -36 | 87 | 0 |
| 30 Sep 19 | 451 | -73 | 100 | 0 |
| 30 Jun 19 | 455 | -63 | 97 | 0 |
| 31 Mar 19 | 457 | -59 | 96 | 0 |
| 31 Dec 18 | 460 | -54 | 92 | 0 |
| 30 Sep 18 | 460 | -34 | 88 | 0 |
| 30 Jun 18 | 462 | -31 | 88 | 0 |
| 31 Mar 18 | 464 | -29 | 87 | 0 |
| 31 Dec 17 | 465 | -44 | 90 | 0 |
| 30 Sep 17 | 464 | -48 | 106 | 0 |
| 30 Jun 17 | 458 | -47 | 109 | 0 |
| 31 Mar 17 | 453 | -44 | 110 | 0 |
| 31 Dec 16 | 446 | -28 | 97 | 0 |
| 30 Sep 16 | 438 | -24 | 107 | 0 |
| 30 Jun 16 | 431 | -14 | 105 | 0 |
| 31 Mar 16 | 422 | -14 | 105 | 0 |
| 31 Dec 15 | 411 | -14 | 104 | 0 |
| 30 Sep 15 | 404 | -12 | 100 | 0 |
| 30 Jun 15 | 398 | -20 | 100 | 0 |
| 31 Mar 15 | 388 | -25 | 99 | 0 |
| 31 Dec 14 | 380 | -24 | 99 | 0 |
| 30 Sep 14 | 367 | -22 | 96 | 0 |
| 30 Jun 14 | 356 | -26 | 94 | 0 |
| 31 Mar 14 | 349 | -19 | 93 | 0 |
| 31 Dec 13 | 344 | -16 | 92 | 0 |
Quality Earnings: SNDA is currently unprofitable.
Growing Profit Margin: SNDA is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: SNDA is unprofitable, but has reduced losses over the past 5 years at a rate of 30.2% per year.
Accelerating Growth: Unable to compare SNDA's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: SNDA is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (10.3%).
Return on Equity
High ROE: SNDA has a negative Return on Equity (-8.6%), as it is currently unprofitable.